Dr. G. V. J. A. Harshavardhan
Kiran Mazumdar Shaw
COVER STORY
“ All vaccines received Emergency Use Authorization in line with WHO guidelines, based on rigorous preclinical and clinical evaluations demonstrating strong safety, efficacy, and immune response.”
Dr. G. V. J. A. Harshavardhan
Director General of the Indian Vaccine Manufacturers Association( IVMA)
“ COVID-19 vaccines developed in India were approved under the EUA framework, following rigorous protocols aligned with global standards for safety and efficacy. To suggest that these vaccines were‘ hastily’ approved is factually incorrect and contributes to public misinformation.”
Kiran Mazumdar Shaw
Executive Chairperson, Biocon Limited
18
BioVoiceNews | July-August 2025